
Federated Hermes seeking shareholder approval related to the Federated Hermes MDT Large Cap Growth ETF
PITTSBURGH , Aug. 9, 2024 /PRNewswire/ -- Federated Hermes, Inc. (NYSE: FHI), a global leader in active investing, today announced that the Board of Trustees of Federated Hermes ETF Trust, on behal...

Medtronic: Lock In This Dividend Aristocrat While It's Still Cheap
Investing in stocks carries risks, but not investing can also be risky, especially with potential declines in savings account yields. Medtronic is a strong dividend aristocrat with top-line growth,...

3 Healthcare Stocks Injecting AI for Big Gains
While the pairing of artificial intelligence and healthcare may sound like something straight out of a science fiction movie, there are several avenues through which the high-speed data processing ...

Blue-Chip Fire Sale: 3 Stocks the Market is Dead Wrong About
If this year's market volatility has you feeling uneasy, you're not alone. The overvaluation of many tech stocks has created a challenging environment, but plenty of affordable, undervalued blue-ch...

Medtronic Digital Transformation Strategy Report 2024: Accelerators, Incubators, and Other Innovation Programs
Dublin, July 01, 2024 (GLOBE NEWSWIRE) -- The "Medtronic Plc - Digital Transformation Strategies" company profile has been added to ResearchAndMarkets.com's offering. The report provides comprehens...

Medtronic (MDT) Shares Positive Data for MiniMed 780G System
Medtronic (MDT) presents more compelling data showcasing the benefits of the MiniMed 780G system.

New MiniMed™ 780G system data demonstrates ability to address persistent blood sugar challenges for people with type 1 diabetes
With its advanced algorithm that provides autocorrections every 5 minutes, the latest data demonstrated that the MiniMed™ 780G system decreased rates of early morning hyperglycemia, known as dawn p...

Medtronic: Now Is The Time To Buy This Deep Value Dividend Aristocrat
When done right, pairing quality and value can be an especially potent investing strategy. Medtronic's revenue edged higher as currency-neutral non-GAAP EPS dipped a bit in the fiscal fourth quarte...

Medtronic: Why I Disagree With The Crowd
MDT stock enjoys a bullish rating from analysts and Seeking Alpha writers. But insider transactions are completely dominated by selling - for good reasons in my view. The valuation is not as attrac...

I'm Buying Dividend Aristocrats With Up To 8.5% Yield
Medtronic and Altria are two value stocks with long track records of raising dividends for over 25 consecutive years. Medtronic is a healthcare technology company with strong revenue growth and a s...

Is Medtronic Stock a Buy?
Medtronic's growth rate has been showing signs of improvement. The company recently announced it would be raising its dividend for the 47th consecutive year.

Medtronic announces pricing of €3.0 billion of senior notes
DUBLIN , May 29, 2024 /PRNewswire/ -- Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned indirect subsidiary, Medtronic, Inc., has priced an offering (the "Offering") o...

Medtronic Stock Could Soar 29%, According to a Wall Street Analyst. Is the Dividend Champion a Buy Now?
Medtronic stock reacted negatively to an earnings report that many Wall Street analysts found encouraging. Wells Fargo raised its price target for Medtronic to $105 per share.

Medtronic's (MDT) OmniaSecure Lead Favored in the LEADR Trial
Medtronic's (MDT) OmniaSecure defibrillation lead demonstrates reliable performance in the LEADR Pivotal trial.

Medtronic Dips: Is Now the Time to Buy?
Shares of Medtronic NYSE: MDT are falling following its FQ4 release and guidance, opening up a potential buying opportunity. The question is whether its value, yield, balance sheet and cash flow ar...
Related Companies